View Section: Company Analysis
Compass Therapeutics Rating
CM
CMPX stock rating score is -4/100. Compass Therapeutics is aExtremely Risky Investment.
The in-depth assessment covers such aspects as the profitability and solvency of the company, management efficiency, and growth sustainability. Our rating serves as an answer to whether the company`s shares are generally reasonable for purchase. The higher company rating score is, the more stock is attractive for investment.
Eyestock Rating
Last update 26.08.2024
-4/100
Low score
Rating Breakdown
Profitability score
-25
/25
Solvency score
46
/25
Efficiency score
-25
/25
Stability score
0
/25
Compass Therapeutics Inc. Rewards and Warnings
The assessment of the quality of a business is based on quantitative analysis of 10 key financials taken from the company's statements. Pay close attention to the cons, if any, before making a decision.
Financial
Check
Value
Net Profit Margin
-5557 %
Earnings quality
—
—
Gross Margin
—
—
Compass Therapeutics Inc.'s Historical Rating
How has the company's valuation changed in the past?
A quick analysis will help you understand how stable financial indicators are overall.
Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Discover High-rated Companies
View Section: Valuation